Transpek Industry Ltd (TRANSPEK) — shareholding pattern, promoter holding, financials and share price

About Transpek Industry Ltd (TRANSPEK)

Transpek Industry Ltd operates in the Commodity Chemicals industry, within the Chemicals sector. It trades on the NSE as TRANSPEK and on the BSE under scrip code 506687. Its ISIN is INE687A01016.

Incorporated in 1965, Transpek Industry Ltd manufactures and exports a range of chemicals [1]

Transpek Industry Limited is a specialty chemical manufacturer focused on chlorinated products and acid chlorides, operating multiproduct plants in Vadodara with a stated aggregate capacity of 66,000 MTPA and a global export footprint across North America, Europe, South America and Eurasia, positioning itself as a leading Indian supplier for polymers, pharma and specialty chemistries.

Recent financials show stable revenues with Q3 FY26 at ₹162.0 crore and 9M FY26 revenue of ₹493.2 crore, while profitability improved with 9M EBITDA rising 14.9% year‑on‑year to ₹95.9 crore and EBITDA margin expanding to c.19.4%, reflecting favourable product mix and cost management despite modest top‑line pressure versus prior periods.

Listed peers in Commodity Chemicals: Petro Carbon & Chemicals Ltd, OCCL Ltd, Primo Chemicals Ltd, POCL Enterprises Ltd, Chemfab Alkalis Ltd, Blue Pearl Agriventures Ltd.

Valuation & Returns

10 Jul 2026

At ₹980.96 a share on 10 Jul 2026, Transpek Industry Ltd (TRANSPEK) was valued at a price-to-earnings ratio of 12x against an industry P/E of 45.11x and a price-to-book of 0.74x on a book value of ₹1,334.37 per share as of Mar 2025. Solomo computes return on equity of 6.12% and return on capital employed of 8.25% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.

P/E
12x
Industry P/E
45.11x
P/B
0.74x
EPS (TTM)
₹81.73
Book value / share
₹1,334.37
ROE
6.12%
ROCE
8.25%
ROA
4.56%
Debt / equity
0.13x
Dividend yield
2.04%
EBITDA margin
18.98%
52-week range
₹864 – ₹1,738

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, Transpek Industry Ltd (TRANSPEK) reported revenue of ₹621 crore, net profit of ₹46 crore and earnings per share of ₹81.73. That compares with revenue of ₹650 crore and net profit of ₹49 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹148.22 crore and net profit ₹6.58 crore (consolidated).

Consolidated annual results for Transpek Industry Ltd (TRANSPEK), Mar 2022 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue (₹ cr)599827580650621
Net profit (₹ cr)6583394946
EPS (₹)117.09149.4669.0387.2681.73
Compound annual growth for Transpek Industry Ltd (TRANSPEK). Stock price CAGR is price return and excludes dividends.
Measure10Y5Y3Y1Y
Sales growth9.19%2.81%2.75%12.11%
Profit growth9.65%-7.75%-9.34%26.40%
Stock price CAGR10%-12%-19%-38%

Ownership Summary

Jun 2026

As of Jun 2026, promoters hold 57.27% of Transpek Industry Ltd (TRANSPEK) (down 0.2 pp QoQ), foreign institutional investors (FII) hold 0.02% and domestic institutional investors (DII) hold 1.05%. Market capitalisation was ₹548 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.

Largest disclosed public shareholders in Jun 2026: MUKUL MAHAVIR AGRAWAL 2.12%, Finquest Securities Private Limited - Proprietary Account 1.8%, GAURAV NARESH LODHA 1.21%, MINAL BHARAT PATEL 1.1%, UNIFI FINANCIAL PRIVATE LIMITED 1.06%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Jun 202657.27%-0.02%1.05%42.73%
Mar 202657.47%-0.02%1.6%42.53%
Dec 202557.47%-0.03%1.64%42.53%
Sep 202557.47%-0.03%1.64%42.53%
Jun 202557.47%-0.04%1.83%42.53%
Mar 202557.47%-0.03%1.86%42.53%
Dec 202457.47%-0.03%1.86%42.53%
Sep 202457.47%-0.05%1.86%42.53%
Every quarter since Mar 2001 Filing data, not investment advice.